Literature DB >> 6137783

Effects of excitatory amino acids on locomotor activity after bilateral microinjection into the rat nucleus accumbens: possible dependence on dopaminergic mechanisms.

B A Donzanti, N J Uretsky.   

Abstract

In order to study the role of excitatory amino acids on motor function, the effects of kainic, quisqualic, and N-methyl-DL-aspartic acids on locomotor activity were determined after their direct injection into the nucleus accumbens. These three amino acids have been used in previous studies to classify receptors for excitatory amino acids in the mammalian spinal cord. After injection into the nucleus accumbens all three amino acids stimulated locomotor activity, with kainic acid being the most potent and N-methyl-DL-aspartic acid the least potent. The maximum intensity of the stimulation produced by kainic and quisqualic acids was greater than that produced by N-methyl-DL-aspartic acid. These results suggest that receptors in the nucleus accumbens, sensitive to kainic and quisqualic acids, play a more important role in the stimulation of locomotor activity than those sensitive to N-methyl-DL-aspartic acid. In addition to the above amino acids, the administration of large doses of L-aspartic and D-glutamic acids also produced hyperactivity, while L-glutamic acid had no effect. To determine whether endogenous dopamine mediates the hypermotility produced by the excitatory amino acids, the response to these amino acids was studied after treatment with reserpine or dopamine receptor blocking agents. Reserpine (5 mg/kg, i.p.), haloperidol (0.8 mg/kg, i.p.) or fluphenazine [5.0 micrograms (total dose) injected into the nucleus accumbens] markedly attenuated the hypermotility induced by excitatory amino acids. These results suggest that the hypermotility produced by excitatory amino acids is mediated through release of dopamine and the subsequent stimulation of dopamine receptors in the nucleus accumbens.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6137783     DOI: 10.1016/0028-3908(83)90213-7

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  17 in total

1.  Involvement of AMPA/Kainate Glutamate Receptor in the Extinction and Reinstatement of Morphine-Induced Conditioned Place Preference: A Behavioral and Molecular Study.

Authors:  Ali Siahposht-Khachaki; Zahra Fatahi; Asal Yans; Fariba Khodagholi; Abbas Haghparast
Journal:  Cell Mol Neurobiol       Date:  2016-04-06       Impact factor: 5.046

2.  Effects of prenatal exposure to 2,4-D/2,4,5-T mixture on postnatal changes in rat brain glutamate, GABA, protein, and nucleic acid levels.

Authors:  F K Mohammad; V E St Omer
Journal:  Bull Environ Contam Toxicol       Date:  1988-02       Impact factor: 2.151

3.  The occurrence of N-methyl-D-aspartic acid in muscle extracts of the blood shell, Scapharca broughtonii.

Authors:  M Sato; F Inoue; N Kanno; Y Sato
Journal:  Biochem J       Date:  1987-01-01       Impact factor: 3.857

4.  Differential behavioral effects following microinjection of an NMDA antagonist into nucleus accumbens subregions.

Authors:  C S Maldonado-Irizarry; A E Kelley
Journal:  Psychopharmacology (Berl)       Date:  1994-09       Impact factor: 4.530

5.  Glutamate-dopamine interactions in the ventral striatum: role in locomotor activity and responding with conditioned reinforcement.

Authors:  L H Burns; B J Everitt; A E Kelley; T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  1994-08       Impact factor: 4.530

6.  The glutamatergic projection from the prefrontal cortex to the nucleus accumbens core is required for cocaine-induced decreases in ventral pallidal GABA.

Authors:  Mary M Torregrossa; X-C Tang; Peter W Kalivas
Journal:  Neurosci Lett       Date:  2008-04-10       Impact factor: 3.046

7.  The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents.

Authors:  L J Bristow; P H Hutson; L Thorn; M D Tricklebank
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

8.  R-(+)-HA-966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamine.

Authors:  P H Hutson; L J Bristow; L Thorn; M D Tricklebank
Journal:  Br J Pharmacol       Date:  1991-08       Impact factor: 8.739

9.  Antagonism of the hypermotility response induced by excitatory amino acids in the rat nucleus accumbens.

Authors:  B A Donzanti; N J Uretsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-01       Impact factor: 3.000

10.  Towards a reconceptualization of striatal interactions between glutamatergic and dopaminergic neurotransmission and their contribution to the production of movements.

Authors:  Hélène N David
Journal:  Curr Neuropharmacol       Date:  2009-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.